These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2529128)

  • 21. Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandil.
    Clapham JC; Wilson C
    J Auton Pharmacol; 1987 Sep; 7(3):233-42. PubMed ID: 2963005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of K-channel openers on the contractility and electrical activity of antral circular muscle in guinea-pig stomach.
    Kim KW; Kim SJ; Jun JY
    J Smooth Muscle Res; 1993 Oct; 29(5):145. PubMed ID: 8167416
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of K+ channel blockers on the relaxant action of dihydralazine, cromakalim and nitroprusside in isolated rabbit femoral arteries.
    Thirstrup S; Nielsen-Kudsk JE
    Eur J Pharmacol; 1992 May; 215(2-3):177-83. PubMed ID: 1396985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta.
    Lebrun P; Fang ZY; Antoine MH; Herchuelz A; Hermann M; Berkenboom G; Fontaine J
    Pharmacology; 1990; 41(1):36-48. PubMed ID: 2122482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of imidazoline-related compounds on the mechanical response to nicorandil in the rat portal vein.
    Okumura K; Ichihara K; Nagasaka M
    Eur J Pharmacol; 1992 May; 215(2-3):253-7. PubMed ID: 1396988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.
    Asano M; Masuzawa-Ito K; Matsuda T
    Eur J Pharmacol; 1994 Sep; 263(1-2):121-31. PubMed ID: 7529710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by glibenclamide of the effects of cromakalim on responses of rat vas deferens to naphazoline.
    Grana E; Barbieri A; Zonta F
    Eur J Pharmacol; 1991 Sep; 202(1):93-6. PubMed ID: 1786804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 31. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nicorandil on human isolated corpus cavernosum and cavernous artery.
    Hedlund P; Holmquist F; Hedlund H; Andersson KE
    J Urol; 1994 Apr; 151(4):1107-13. PubMed ID: 8126802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of taurine on the reactivity of aortas from diabetic rats.
    Abebe W
    Life Sci; 2008 Jan; 82(5-6):279-89. PubMed ID: 18174109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of cromakalim-induced relaxations in the smooth muscle cells of guinea-pig mesenteric artery and vein.
    Nakao K; Okabe K; Kitamura K; Kuriyama H; Weston AH
    Br J Pharmacol; 1988 Nov; 95(3):795-804. PubMed ID: 2974740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cromakalim-induced relaxation of guinea-pig isolated trachealis: antagonism by glibenclamide and by phentolamine.
    Murray MA; Boyle JP; Small RC
    Br J Pharmacol; 1989 Nov; 98(3):865-74. PubMed ID: 2511995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of potassium channel toxins from Leiurus quinquestriatus hebraeus venom on responses to cromakalim in rabbit blood vessels.
    Strong PN; Weir SW; Beech DJ; Hiestand P; Kocher HP
    Br J Pharmacol; 1989 Nov; 98(3):817-26. PubMed ID: 2531622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cromakalim and nicorandil on intraocular pressure after topical administration in rabbit eyes.
    Chiang CH; Lin CH
    J Ocul Pharmacol Ther; 1995; 11(3):195-201. PubMed ID: 8590250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K
    Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.